2/22/2021 1:32:00 AM New Drugs Approved In January 1/23/2021 2:51:35 AM FDA Approves Aurinia Pharma's Lupkynis - Second Lupus Nephritis Drug In A Month 1/22/2021 5:37:33 AM Pre-market Movers In Healthcare Sector: ADMP, FLDM, ATOS, AUPH, SENS

2021-03-19 · The new note on the price target was released on November 03, 2020, representing the official price target for Aurinia Pharmaceuticals Inc. stock. Previously, the target price had yet another raise to $20, while BTIG Research analysts kept a Buy rating on AUPH stock.

AUPH Quick Quote AUPH Negative Net Change CTLT Quick Quote CTLT Negative Net Change Aurinia Announces U.S. Food And Drug Administration Acceptance Of The Filing Of New Drug Application And Priority Review For Voclosporin For The Treatment Of Lupus Nephritis By Business Wire Jul Description: Get the latest Aurinia Pharmaceuticals, Inc. (AUPH) stock news and headlines to stay up to date and make informed investing and trading decisions. Aurinia Pharmaceuticals (AUPH) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH, TSX:AUP) (Aurinia or the Company) today announced a favorable assessment regarding the cost-effectiveness and value of LUPKYNIS™ (voclosporin), based on an independent analysis issued by the Institute for Clinical and Economic Review (ICER) in a revised Evidence Report issued on March 12, 2021. AUPH's price/sales ratio is 32.17; that's higher than the P/S ratio of 92.66% of US stocks. As for revenue growth, note that AUPH's revenue has grown 15,660.38% over the past 12 months; that beats the revenue growth of 99.86% of US companies in our set.

Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Aurinia Pharmaceuticals against related stocks people have also bought. 2021-03-15 · View the latest Aurinia Pharmaceuticals Inc. (AUPH) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-03-19 · The new note on the price target was released on November 03, 2020, representing the official price target for Aurinia Pharmaceuticals Inc. stock. Previously, the target price had yet another raise to $20, while BTIG Research analysts kept a Buy rating on AUPH stock. 2019-12-26 · Investors in Aurinia Pharmaceuticals Inc (Symbol: AUPH) saw new options become available this week, for the February 2020 expiration. At Stock Options Channel, our YieldBoost formula has looked up 2021-03-24 · The AUPH stock was last observed hovering at around $13.27 in the last trading session, with the day’s loss setting it -0.41% off its average median price target of $28.00 for the next 12 months. It is also 63.26% off the consensus price target high of $35.00 offered by 9 analysts, but current levels are 28.16% higher than the price target low of $17.90 for the same period. AUPH - Aurinia Pharmaceuticals Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com.

Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock quote, history, news and other vital information to help you with your stock trading and investing.

CALM -6% tillkännagivna intäkter, saknar EPS och intäkter. News release from Vestas Asia Pacific Singapore, 18 August 2020 Vestas has signed an 86 MW contract with Nexif Energy for the auPh: +61 404 003 061.

Find the latest news headlines from Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) at Nasdaq.com.

Those same 5 YEARS313.06%. SUMMARYNEWSPROFILEDIVIDENDSCOMPETITORS. SUMMARY - AUPH: Aurinia Pharmaceuticals Inc. CLOSING AUPH STOCK PRICE Mar 2, 2021 Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the interested parties can access the live webcast under "News/Events” through Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock quote, history, news and other vital information to help you with your stock trading and investing.

Free forex prices, toplists, indices and lots more. NEW YORK, NY / ACCESSWIRE / February 24, 2021 / Aurinia Pharmaceuticals, Inc. (NASDAQ:AUPH) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 24, Aurinia Announces U.S. Food And Drug Administration Acceptance Of The Filing Of New Drug Application And Priority Review For Voclosporin For The Treatment Of Lupus Nephritis By Business Wire Jul 2010-01-01 AUPH NEWS - IBD PARTNERS; IBD. Aurinia Pharmaceuticals Scores Relative Strength Rating Upgrade Investor's Business Daily 10/09/2020 03:00 AM ET. Aurinia Pharmaceuticals Scores Relative Strength Get Aurinia Pharmaceuticals Inc (AUPH:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. 2020-04-27 AUPH News; Overall. AUPH Stock Analysis Overview.
Teliase efaktura

View the real-time AUPH price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Aurinia Pharmaceuticals against related stocks people have also bought. 2021-03-15 · View the latest Aurinia Pharmaceuticals Inc. (AUPH) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-03-19 · The new note on the price target was released on November 03, 2020, representing the official price target for Aurinia Pharmaceuticals Inc. stock. Previously, the target price had yet another raise to $20, while BTIG Research analysts kept a Buy rating on AUPH stock.

Yahoo. Aurinia (AUPH) Gets FDA Jan 25, 2021 Aurinia (AUPH) gets approval from the FDA for Lupkynis as a comSubscribe now to stay ahead with the most trusted business news source.
Fastighetsskatt bostadsrätt

AUPH received much-anticipated FDA approval for its drug with the commercial name Lupkynis for the treatment of lupus nephritis, which is an "unpenetrated therapeutic area." The FDA approval

Lifestyle. Fashion Guide. Living.